idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - inmunosupresores - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
zolvix
elanco gmbh - monepantel - los antihelmínticos, - oveja - la solución oral de zolvix es un antihelmíntico de amplio espectro para el tratamiento y control de infecciones por nematodos gastrointestinales y enfermedades asociadas en ovinos, incluidos corderos, cerdos, carneros de cría y ovejas.. spectrum of activity includes fourth larvae and adults of: , haemonchus contortus*;, teladorsagia circumcincta*;, teladorsagia trifurcata*;, teladorsagia davtiani*;, trichostrongylus axei*;, trichostrongylus colubriformis;, trichostrongylus vitrinus;, cooperia curticei;, cooperia oncophora;, nematodirus battus;, nematodirus filicollis;, nematodirus spathiger;, chabertia ovina;, oesophagostomum venulosum. * , incluyendo larvas inhibidas. el medicamento veterinario es eficaz contra cepas de estos parásitos resistentes a (pro) bencimidazoles, levamisol, morantel, lactonas macrocíclicas y h. cepas de contortus resistentes a las salicilanilidas.
oxydrench suspension oral # duotech suspension oral
norbrook laboratories (ireland) limited - oxfendazol - suspensiÓn oral - oxfendazol 25 - antihelmÍnticos - ovino
palforzia
aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - otros tracto alimentario y metabolismo de los productos, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.
hapasil suspension oral 150 mg/ml
merck sharp & dohme animal health sl - netobimina - suspensiÓn oral - - netobimina - bovino
hapasil suspension oral 50 mg/ml
merck sharp & dohme animal health sl - netobimina - suspensiÓn oral - - netobimina - ovino
recombinate 1000 ui polvo y disolvente para solucion inyectable
baxalta spain s.l. - octocog alfa - polvo y disolvente para soluciÓn inyectable - 1.000 ui - octocog alfa 1000 ui - factor viii de la coagulación
recombinate 250 ui polvo y disolvente para solucion inyectable
baxalta spain s.l. - octocog alfa - polvo y disolvente para soluciÓn inyectable - 250 ui - octocog alfa 250 ui - factor viii de la coagulación
recombinate 500 ui polvo y disolvente para solucion inyectable
baxalta spain s.l. - octocog alfa - polvo y disolvente para soluciÓn inyectable - 500 ui - octocog alfa 500 ui - factor viii de la coagulación